You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (237)

Journals (0)

1-10 of 237 results for human epidermal growth factor receptor 2-negative breast cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population

Retricted access

Research article

First published 2022-10

Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population

Rocío Díaz-Acedo, Silvia Artacho Criado, Rocío Jiménez Galán [...]

Journal of Oncology Pharmacy Practice

Select article: Platelet-to-lymphocyte ratio as a prognostic biomarker in patients with human epidermal growth factor receptor 2-negative breast cancer undergoing taxane–carboplatin-based neoadjuvant chemotherapy

Open access

Research article

First published 2025

Platelet-to-lymphocyte ratio as a prognostic biomarker in patients with human epidermal growth factor receptor 2-negative breast cancer undergoing taxane–carboplatin-based neoadjuvant chemotherapy

Qiuyan Huang, Kai Huang, Jinxian Qian [...]

Therapeutic Advances in Medical Oncology

Select article: Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Open access

Review article

First published 2015

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Adam M. Brufsky

Clinical Medicine Insights: Oncology

Select article: Combination of Palbociclib and Endocrine Therapy in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With or Without Brain Metastases

Open access

Research article

First published 2024

Combination of Palbociclib and Endocrine Therapy in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With or Without Brain Metastases

Qiuyi Zhang, Xiaofeng Lan, Jiayi Huang [...]

Technology in Cancer Research & Treatment

Select article: Everolimus treatment in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer and a predictive model for its efficacy: a multicenter real-world study

Open access

Research article

First published 2024

Everolimus treatment in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer and a predictive model for its efficacy: a multicenter real-world study

Yujing Tan, Zexi Peng, Hanfang Jiang [...]

Therapeutic Advances in Medical Oncology

Select article: Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient’s follow up?

Free access

Research article

First published 2015-5

Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient’s follow up?

Nesrine Mejri, H. Boussen, S. Labidi [...]

Therapeutic Advances in Medical Oncology

Select article: Prevalence and clinicopathological features of human epidermal growth factor receptor-2–low breast cancers: A single-center experience

Open access

Research article

First published 2025-5

Prevalence and clinicopathological features of human epidermal growth factor receptor-2–low breast cancers: A single-center experience

ılkay Cinar

Journal of International Medical Research

Select article: Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment

Retricted access

Research article

First published 2019-1

Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment

S Parylo, A Vennepureddy, V Dhar [...]

Journal of Oncology Pharmacy Practice

Select article: Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2,HER3,and HER4)

Open access

Research article

First published 2017-6

Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2,HER3,and HER4)

Marianne Nordlund Broughton, Arne Westgaard, Elisabeth Paus [...]

Tumor Biology

Select article: HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells

Open access

Research article

First published 2017-3

HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells

Krisha Desai, Radhika Aiyappa, Jyothi S Prabhu [...]

Tumor Biology

1
2
3
•••
24
10 / page

Article type

Publication date

Subjects

Access